Consider that HH has been working/leading this P.M. process initiative for a long time. He has pushed the FDA and other process leaders to wake up and smell the coffee. He now has an opportunity to relate results of P.M. process. Yes, we acknowledge it is early yet and we still have a lot to learn , BUT, it is a lot better that ...sorry, you CNS disease is untreatable. This may be a Fleming moment.
IMO, the best part of this first step is where it leads. Now, the best minds will have a tool suite and process which seems certain to lead to a cascade of binary events for CNS disease treatments while AVXL have front row seats. Pilots and crews report to your ready rooms.